Efficacy and Safety of CT-P13 in Inflammatory Bowel Disease...

BioDrugs 2020 / 10 Vol. 34; Iss. 5

Efficacy and Safety of CT-P13 in Inflammatory Bowel Disease after Switching from Originator Infliximab: Exploratory Analyses from the NOR-SWITCH Main and Extension Trials

Jørgensen, Kristin K., Goll, Guro L., Sexton, Joe, Bolstad, Nils, Olsen, Inge C., Asak, Øivind, Berset, Ingrid P., Blomgren, Ingrid M., Dvergsnes, Katrine, Florholmen, Jon, Frigstad, Svein O., Henri
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
34
Journal:
BioDrugs
DOI:
10.1007/s40259-020-00438-7
Date:
October, 2020
File:
PDF, 1.89 MB
2020
Conversion to is in progress
Conversion to is failed